Jonah Larkins-Ford

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 8

Top Topics

Mycobacterium Tuberculosis

Electronic Health Record

Top Venues

Expert opinion on drug discovery

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Jonah Larkins-Ford, Bree B Aldridge
Advances in the design of combination therapies for the treatment of tuberculosis. Expert opinion on drug discovery (2022)
Jonah Larkins-Ford, Bree B Aldridge
Advances in the design of combination therapies for the treatment of tuberculosis. Expert opinion on drug discovery 18 (1) (2022)
Jonah Larkins-Ford, Bree B Aldridge
Advances in the design of combination therapies for the treatment of tuberculosis. Expert opinion on drug discovery 18 (1) (2022)
Jonah Larkins-Ford, Bree B Aldridge
Advances in the design of combination therapies for the treatment of tuberculosis. Expert opinion on drug discovery (2022)
Jonah Larkins-Ford, Bree B Aldridge
Advances in the design of combination therapies for the treatment of tuberculosis. Expert opinion on drug discovery (2022)
Jonah Larkins-Ford, Bree B Aldridge
Advances in the design of combination therapies for the treatment of tuberculosis. Expert opinion on drug discovery 18 (1) (2022)
Jonah Larkins-Ford, Bree B Aldridge
Advances in the design of combination therapies for the treatment of tuberculosis. Expert opinion on drug discovery 18 (1) (2022)
Trever C Smith, Krista M Pullen, Michaela C Olson, Morgan E McNellis, Ian Richardson, Sophia Hu, Jonah Larkins-Ford, Xin Wang, Joel S Freundlich, D Michael Ando, Bree B Aldridge
Morphological profiling of tubercle bacilli identifies drug pathways of action. Proceedings of the National Academy of Sciences of the United States of America 117 (31) (2020)